Effect of PRM1201 Combined With Adjuvant Chemotherapy on Preventing Recurrence and Metastasis of Stage III Colon Cancer: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Ru Jia(Shanghai University of Traditional Chinese Medicine), Qi Li(Qingdao University), Huaimin Liu(Shanghai University of Traditional Chinese Medicine), Youying Lai(Shanghai University of Traditional Chinese Medicine), Xiaoting Sun(Tianjin University of Traditional Chinese Medicine), Qing Ji(Shanghai University of Traditional Chinese Medicine), Yuanyuan Feng(Shanghai University of Traditional Chinese Medicine), Guoxiang Cai(Shanghai Medical College of Fudan University), Ling Zhao(Shanghai University of Traditional Chinese Medicine), Yan Wang(Central South University), Hui Liu(Shanghai University of Traditional Chinese Medicine), Yi Zhang(Tianjin Medical University General Hospital), Ningning Liu(Shuguang Hospital), Yanbo Zhang(Albert Einstein College of Medicine), Yun Zhang(Janssen (Belgium)), Chaojun Wu(Shanghai University of Traditional Chinese Medicine), Gang Han(Shanghai University of Traditional Chinese Medicine), Hongjie Liu(Jinan University), Lihong Zhou(Jiangnan University), Xiaoqiang Yue(Second Military Medical University), Haijuan Xiao(Affiliated Hospital of Shaanxi University of Chinese Medicine), Zhifen Han(Unknown), Puhua Zeng(Hunan Academy of Traditional Chinese Medicine), Hangjun Gong(Shuguang Hospital), Jiege Huo(Nanjing University of Chinese Medicine)
Cited by 14
Related Papers
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
|The Lancet|2020|29.1k
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
|New England Journal of Medicine|2020|5.5k
The Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer
|Cellular Physiology and Biochemistry|2017|4.1k
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
Roles of IFN-γ in tumor progression and regression: a review
|Biomarker Research|2020|1.2k